Free Trial

Aurora Cannabis (ACB) Stock Forecast & Price Target

C$7.88
+0.03 (+0.38%)
(As of 07/19/2024 ET)

Aurora Cannabis - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Based on 4 Wall Street analysts who have issued ratings for Aurora Cannabis in the last 12 months, the stock has a consensus rating of "Hold." Out of the 4 analysts, 3 have given a hold rating, and 1 has given a buy rating for ACB.

Consensus Price Target

C$4.71
-40.23% Downside
High ForecastC$11.00
Average ForecastC$4.71
Low ForecastC$0.80

According to the 4 analysts' twelve-month price targets for Aurora Cannabis, the average price target is C$4.71. The highest price target for ACB is C$11.00, while the lowest price target for ACB is C$0.80. The average price target represents a forecasted downside of -40.23% from the current price of C$7.88.

TypeCurrent Forecast
7/20/23 to 7/19/24
1 Month Ago
6/20/23 to 6/19/24
3 Months Ago
4/21/23 to 4/20/24
1 Year Ago
7/20/22 to 7/20/23
Consensus Rating
Hold
Hold
Hold
Hold
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
1 Buy rating(s)
1 Buy rating(s)
1 Buy rating(s)
0 Buy rating(s)
Hold
3 Hold rating(s)
2 Hold rating(s)
2 Hold rating(s)
5 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price TargetC$4.71C$3.14C$2.26C$1.46
Forecasted Upside-40.23% Downside10.48% Upside2.92% Upside23.07% Upside
Get Aurora Cannabis Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for ACB and its competitors with MarketBeat's FREE daily newsletter.

ACB Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

ACB Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Aurora Cannabis Stock vs. The Competition

TypeAurora CannabisMedical Companies
Consensus Rating Score
2.25
2.72
Consensus RatingHoldModerate Buy
News Sentiment RatingNeutral News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
6/21/2024ATB Capital
4 of 5 stars
 Lower TargetSector PerformC$12.50 ➝ C$11.00+52.78%
2/27/2024Jefferies Financial Group
2 of 5 stars
 Lower TargetHoldC$6.12 ➝ C$4.95+11.24%
2/21/2024CIBC
3 of 5 stars
 Lower TargetNeutralC$6.00+31.87%
2/9/2024Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ BuyC$0.80+37.93%
8/11/2023Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetC$1.00 ➝ C$0.80+11.11%
6/16/2023TD Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetC$1.30 ➝ C$1.00+42.86%
2/13/2023Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetC$1.45 ➝ C$1.20-3.23%
9/21/2022Atb Cap Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
F. Gomes
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeUnderperform ➝ Sector Perform
9/21/2022Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutralC$4.00+128.57%
7/19/2022Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetC$1.85 ➝ C$2.00+2.04%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 08:25 PM ET.

ACB Forecast - Frequently Asked Questions

What is Aurora Cannabis' forecast for 2024?

According to the research reports of 4 Wall Street equities research analysts, the average twelve-month stock price forecast for Aurora Cannabis is C$4.71, with a high forecast of C$11.00 and a low forecast of C$0.80.

Should I buy or sell Aurora Cannabis stock right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aurora Cannabis in the last twelve months. There are currently 3 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" ACB shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ACB, but not buy additional shares or sell existing shares.

Does Aurora Cannabis's stock price have much upside?

According to analysts, Aurora Cannabis's stock has a predicted upside of 23.66% based on their 12-month stock forecasts.

What analysts cover Aurora Cannabis?

Aurora Cannabis has been rated by research analysts at ATB Capital in the past 90 days.

Do Wall Street analysts like Aurora Cannabis more than its competitors?

Analysts like Aurora Cannabis less than other "medical" companies. The consensus rating for Aurora Cannabis is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how ACB compares to other companies.


This page (TSE:ACB) was last updated on 7/19/2024 by MarketBeat.com Staff

From Our Partners